Call for Abstract
Scientific Program
7th International Conference on Womens Health, Reproduction and Fertility, will be organized around the theme “ "Reproductive Health and Fertility Preservation: Addressing Modern Challenges"”
REPRODUCTION FERTILITY 2025 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in REPRODUCTION FERTILITY 2025
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
The treatment and diagnosis of diseases and ailments that affect women's physical and emotional well-being is the focus of the medical specialty known as women's health. In general, women and men have similar health problems; the only difference is that women's health needs to be specifically taken into account. Young women's health issues, adolescence, pregnancy, and delivery are all biological processes. Women's health is significant because they have unique healthcare needs and have a higher likelihood than men of receiving a diagnosis for a certain condition. Chronic conditions like diabetes, heart disease, cancer, and diabetes are among the leading causes of death in women. The intriguing health conditions that affect women include menopause, abnormalities of the female organs, and pregnancy. The two medical procedures that pose the greatest health hazards to young women between the ages of 15 and 19 are becoming pregnant and giving birth.
- Chronic diseases
- Heart disease
- Diabetes
Reproduction Fertility 2025 | Women Health 2025 | Reproductive Health & Fertility | Assisted Reproductive Technologies (ART) | Maternal & Child Health Congress | Gynecology & Obstetrics Conference
World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG)
This track explores cutting-edge advancements in assisted reproductive technologies (ART) and precision medicine. From IVF and hormonal therapies to genetic screening and AI-based fertility prediction, these innovations are transforming fertility care. Topics include infectious disease risks, disorders of sex development, and ethical concerns in reproductive interventions. Emphasis is placed on personalized treatments and digital tools that enhance reproductive outcomes.
Key Topics:
- IVF, ICSI, and cryopreservation
- Genetic screening and counseling
- AI in fertility prediction
- Digital biomarkers and wearables
- Medico legal issues
Assisted Reproductive Technologies (ART) | Maternal & Child Health Congress | Gynecology & Obstetrics Conference| Hormonal Imbalance & Fertility | Pregnancy & Neonatal Care | Infertility Treatment & IVF
European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI)
Stem cells are undifferentiated cells having the ability to self-replicate and specialize into distinct cell types. The two main properties of stem cells are self-renewal and potency, which allow them to differentiate into any form of cell. Ovaries do contain stem cells that develop into oocytes in adults and can be created in vitro to produce children, according to studies published offered novel validation of the endometrial healing caused by stem cells in patients who had bone marrow transplants. It is feasible to use this research to treat uterine issues. Regenerative medicine is opening new avenues in reproductive health through stem cell technologies. This track explores tissue repair, regeneration, and restoration of reproductive capacity.
- Infections
- Reproductive tract infection
- Ovarian and endometrial stem cell therapy
- Uterine bioengineering
- Germ cell development from stem cells
- Regenerative applications in reproductive surgery
Reproductive Health & Fertility | Assisted Reproductive Technologies (ART) | Maternal & Child Health Congress | Gynecology & Obstetrics Conference| Hormonal Imbalance & Fertility | Pregnancy & Neonatal Care
American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS)
Fertility is the capacity to conceive and bear children. It is influenced by multiple factors such as age, lifestyle, hormones, genetics, and underlying health conditions. The most fertile period is during ovulation, typically between days 11–21 of the menstrual cycle. Age-related fertility decline, obesity, and disorders like Postmenopausal girls, PCOS and endometriosis are common challenges. Key causes of infertility include:
- Polycystic ovarian syndrome
- Endometriosis
- Tubal blockages
- Advanced maternal age
- Female fertility
- Low egg quantity and quality
- Male factor infertility
Maternal & Child Health Congress | Gynecology & Obstetrics Conference| Hormonal Imbalance & Fertility | Pregnancy & Neonatal Care | Infertility Treatment & IVF | Endometriosis & PCOS Meet | Menopause & Aging Congress
Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA)
Sterility in men is treated with
- Surgery, if the cause is a varicocele( widening of the modes in the scrotum) or a vas deferens inhibition.
- Antibiotics to clean up impurity in the genitalia.
- Drug and comforting to treat construction or interjection problems.
- Hormone curatives if a hormone imbalance is the cause of the issue.
Sterility in women is treated with
• Fertility medicines and hormones to help in reestablishing hormone situations and induce ovulation in the case.
• Surgery to open dammed fallopian tubes or remove towel that's precluding fertility
In vitro fertilization is a type of supported reproductive technology used to treat gravidity. In IVF, sperm and an egg are fertilized in a liquid media outside of the body.
Gynecology & Obstetrics Conference| Hormonal Imbalance & Fertility | Pregnancy & Neonatal Care | Infertility Treatment & IVF | Endometriosis & PCOS Meet | Menopause & Aging Congress
American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO)
This track provides a comprehensive overview of women’s reproductive health across the life span, with a particular emphasis on pregnancy and childbirth. Obstetrics ensures the safety of mother and child before, during, and after delivery, while gynecology focuses on diagnosing and treating conditions related to the female reproductive system. It also addresses common gynecologic concerns such as fibroids and uterine anomalies, as well as challenges like malignant tumors and pelvic inflammatory disease.
Key Topics:
- Prenatal care and fetal monitoring
- Cesarean section and labor induction
- Maternal care and postnatal wellness
- Menstrual disorders and menopause
- Malignant tumors and reproductive diagnostics
Menopause & Aging Congress | Reproduction Fertility 2025 | Women Health 2025 | Reproductive Health & Fertility | Assisted Reproductive Technologies (ART) | Maternal & Child Health Congress | Gynecology & Obstetrics Conference
World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG)
Drugs are commonly used to correct various anomalies during pregnancy. Drugs are often used to treat illnesses during pregnancy when the potential benefits outweigh the known hazards. The most frequently given drugs include antibiotics, analgesics, antihistamines, antiemetics, and tranquillizers. The growth and development of the foetus may be impacted by drug use later in pregnancy. Drugs that may have an impact on foetal development include angiotensin, antithyroid medications, benzodiazepines, blockers, and other medications. But in the UK, every single pregnant woman receives at least one course of medication treatment advice (no less than 33%).
- Tranquillizers
- Antihistamines
- Antiemetic’s
- Analgesics
- Antibiotics
Reproductive Health & Fertility | Assisted Reproductive Technologies (ART) | Maternal & Child Health Congress | Gynecology & Obstetrics Conference| Hormonal Imbalance & Fertility | Pregnancy & Neonatal Care
European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI)
Peripartum analgesia for labor and anesthesia for caesarean deliveries are provided by the anesthesia subspecialty known as obstetric anesthesia, often known as ob-gyn anesthesia or ob-gyn anesthesiology. For the attending anesthesiologists, it has always been challenging to give anesthesia during pregnancy for both obstetric and non-obstetric surgery. While a substantial percentage of an obstetric anesthesiologist's practice may involve directing anesthesia for caesarean sections and managing pain during vaginal deliveries, the specialty is increasingly growing to include anesthesia for both maternal and foetal operations. When labour pains are present, obstetric anesthetists are commonly called upon. Buprenorphine is the medication that is most usually used to produce a more pronounced physical square.
- Obstetric anesthesia
- Obstetric Anesthesiology
Assisted Reproductive Technologies (ART) | Maternal & Child Health Congress | Gynecology & Obstetrics Conference| Hormonal Imbalance & Fertility | Pregnancy & Neonatal Care | Infertility Treatment & IVF
Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA)
Human development is sensitive during the teenage years. It represents the passage from childhood to actual and intellectual adulthood. The Sub-Saharan region has the largest incidence of early childbearing practices, with birth rates among teens exceeding 200 per 1,000 women between the ages of 15 and 19. The Central African Republic, Niger, Chad, Angola, and Mali (with a rate of teenage births above 180) are the countries with the highest rates of teenage births. Maternal health is the condition of women prior to, during, and following childbirth. Healthcare for family planning, conception, pregnancy, labour, and delivery is all included. Discharge, unsafe abortions, and labour obstruction are the leading causes of maternal morbidity and mortality.
- Maternal morbidity and mortality
- Maternal Health
Pregnancy & Neonatal Care | Infertility Treatment & IVF | Endometriosis & PCOS Meet | Menopause & Aging Congress | Reproduction Fertility 2025 | Women Health 2025 | Reproductive Health & Fertility |
Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM)
PCOS is a common hormonal disorder that affects women who are fertile. It is a collection of symptoms brought on by females' increased androgen levels. Heavy periods, irregular or non existent menstrual cycles, excessive body and facial hair, acne, pelvic pain, difficulties getting pregnant, and areas of thick, darker, smoother skin are some of the signs and symptoms of PCOS. Both inherited and environmental factors contribute to it. It's past cure. Birth control pills may benefit acne, excessive hair growth, and regular menstrual cycles. Metformin and anti-androgens may also be beneficial. Weight loss, the use of metformin, and clomiphene are all methods to boost fertility. In vitro fertilization is another technique used. It is the endocrine disorder that affects women the most commonly between the ages of 18 and facial hair
- Excessive body
- Heavy periods
- Acne
- Pelvic pain
Endometriosis & PCOS Meet | Menopause & Aging Congress | Reproduction Fertility 2025 | Women Health 2025 | Reproductive Health & Fertility | Assisted Reproductive Technologies (ART) | Maternal & Child Health Congress
Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE)
Sexually transmitted infections are illnesses that are spread by sexual contact, including anal, oral, and vaginal sex. The symptoms of this condition include pelvic pain, ulcers on or around the genitalia, vaginal discharge, penile discharge, and ulcers. The three groups include bacterial infections, viral STIs, and parasitic STIs. Among the bacterial infections are gonorrhoea, chlamydia, and syphilis. Viral diseases include genital herpes, genital warts, and HIV/AIDS. An illustration is the parasitic STI trichomoniasis. Less dangerous sexual activities are employed. In the classroom, thorough sex education is also advantageous.
- Pelvic pain
- Vaginal discharge
- Penile discharge
- HIV/AIDS
Infertility Treatment & IVF | Endometriosis & PCOS Meet | Menopause & Aging Congress | Reproduction Fertility 2025 | Women Health 2025 | Reproductive Health & Fertility | Assisted Reproductive Technologies (ART)
Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE)
Reproductive malignancies are brought on by the unchecked growth and multiplication of abnormal cells that arise in the reproductive organs. Gynaecologic tumours in women are often found in the United States. 91,730 new cases are estimated to be investigated in the United States this year alone; tragically, 28,080 deaths are anticipated. The most common treatments for reproductive cancers include chemotherapy, surgery, radiation therapy, hormone therapy, or a combination of these.
- Cancer of the uterus
- Ovarian cancer
- Regular pelvic examinations
Reproduction Fertility 2025 | Women Health 2025 | Reproductive Health & Fertility | Assisted Reproductive Technologies (ART) | Maternal & Child Health Congress | Gynecology & Obstetrics Conference| Hormonal Imbalance & Fertility
International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG)
Reproductive endocrinology is the study of hormonal function and dysfunction across a woman's reproductive lifespan from adolescence to menopause. It encompasses the regulation of fertility, menstrual health, gametogenesis, and embryonic development through complex interactions between the pituitary, ovaries, and other endocrine glands. This track also investigates endocrine disorders that impact fertility and the role of reproductive medicine and assisted technologies like IVF in restoring hormonal balance and reproductive capacity.
Key Topics:
- Hypothalamic-pituitary-ovarian axis dysfunction
- Hormonal regulation and fertility evaluation
- Endocrine-related causes of infertility (e.g., PCOS, endometriosis)
- Ovulation induction and hormonal therapy
- In vitro fertilization and reproductive hormone control
- Male reproductive endocrinology
- Gynecological endocrine disorders hormones
Hormonal Imbalance & Fertility | Pregnancy & Neonatal Care | Infertility Treatment & IVF | Endometriosis & PCOS Meet | Menopause & Aging Congress | Reproduction Fertility 2025
Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM)
This track focuses on the neuroendocrine mechanisms that influence reproduction by integrating brain function with hormonal signals. It highlights how neural control affects the hypothalamus-pituitary-gonadal axis and how stress, neurotransmitters, and brain aging impact reproductive health, psychological and behavior.
Key Topics:
- GnRH pulse regulation and hypothalamic signaling
- Neurotransmitters in reproductive physiology
- Stress, amenorrhea, and ovulation suppression
- Neuroendocrinology control of puberty and menopause
- Brain–reproductive system interaction and behavioral aspects
- Neurological changes during reproductive transitions
Gynecology & Obstetrics Conference| Hormonal Imbalance & Fertility | Pregnancy & Neonatal Care | Infertility Treatment & IVF | Endometriosis & PCOS Meet | Menopause & Aging Congress
Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO)
Emotional and psychological well-being is vital across all stages of reproductive life from preconception and fertility treatments to pregnancy, postpartum recovery, and menopause. This track explores how reproductive events can influence mental health, highlighting conditions such as depression, anxiety, and perinatal mood disorders. It emphasizes the importance of early screening, integrated mental health care, and supportive counseling to improve outcomes for both mothers and families. Special focus is placed on the
- Psychological effects of infertility and miscarriage
- Postpartum depression and perinatal anxiety disorders
- Stress and IVF outcomes
- Mental health integration into fertility and maternal care
- Counseling, peer support, and therapeutic interventions
- Mood and cognitive changes during menopause
Women Health 2025 | Reproductive Health & Fertility | Assisted Reproductive Technologies (ART) | Maternal & Child Health Congress | Gynecology & Obstetrics Conference| Hormonal Imbalance & Fertility
American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS)
Menopause marks a significant hormonal and physiological transition in a woman's life, often accompanied by symptoms that impact physical and emotional well-being. This track explores the multifaceted effects of menopause and offers evidence-based strategies to support healthy aging and improve quality of life.
Key Topics:
- Hormone replacement therapy (HRT)
- Menopausal symptom management
- Bone and cardiovascular health
- Cognitive wellness and aging
- Lifestyle approaches for healthy aging
Hormonal Imbalance & Fertility | Pregnancy & Neonatal Care | Infertility Treatment & IVF | Endometriosis & PCOS Meet | Menopause & Aging Congress | Reproduction Fertility 2025 | Women Health 2025
Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO)
Male reproductive health is essential to fertility outcomes. This track covers diagnostics, treatment, and innovations.
• Semen analysis and DNA fragmentation
• Varicocele management and surgery
• Hormonal therapy for male infertility
• Male fertility preservation techniques
• Environmental and lifestyle impacts
Women Health 2025 | Reproductive Health & Fertility | Assisted Reproductive Technologies (ART) | Maternal & Child Health Congress | Gynecology & Obstetrics Conference| Hormonal Imbalance & Fertility
International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS)
The human microbiome is a crucial but often overlooked factor in reproductive wellness. This track explores microbiota in relation to fertility, pregnancy, and gynecological health.
• Vaginal microbiome and infection resistance
• Gut microbiota's impact on estrogen metabolism
• Microbiome and IVF outcomes
• Dysbiosis and miscarriage
• Probiotics and therapeutic modulation
Pregnancy & Neonatal Care | Infertility Treatment & IVF | Endometriosis & PCOS Meet | Menopause & Aging Congress | Reproduction Fertility 2025 | Women Health 2025
Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM)
This track delves into how immune responses affect fertility, embryo implantation, and pregnancy outcomes. It covers immune tolerance, inflammation, and recurrent implantation failure.
Key Topics:
- Maternal immune tolerance
- Immunological causes of infertility
- Recurrent implantation failure
- Immune modulation in IVF
- Cytokines and endometrial receptivity
Hormonal Imbalance & Fertility | Pregnancy & Neonatal Care | Infertility Treatment & IVF | Endometriosis & PCOS Meet | Menopause & Aging Congress | Reproduction Fertility 2025 | Women Health 2025
Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO)